JP

James Porter

CEO

Nuvalent, Inc.

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nuvalent, Inc.
Industry
research
Employees
190.0
Seniority
C suite

Technologies

NetSuite Mimecast Outlook Google Cloud Hosting Amazon AWS Mobile Friendly WordPress.org Google Tag Manager reCAPTCHA Typekit Nginx Piwik Remote AI

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research targeted therapies cancer treatment kinase inhibitors oncology drugs small molecules drug resistance clinical trials biopharmaceuticals precision medicine structure-based drug design pipeline development nsclc alk-positive ros1-positive molecular oncology pharmaceutical development medical affairs regulatory affairs clinical operations drug discovery translational research adverse event mitigation durable responses small-molecule therapeutics patient-centric approach immunotherapy healthcare advancement drug approval processes fda submissions oncogenesis biotechnology pharmacovigilance data management market access program management quality assurance human resources in biotech leadership in oncology financial strategy market analytics commercial strategy clinical supply chain biostatistics medicinal chemistry compound management patient needs assessment target selectivity pharmaceutical compliance life sciences innovation health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans